scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1191/0961203304LU2049XX |
P698 | PubMed publication ID | 15645755 |
P50 | author | Manuel Ramos-casals | Q42646201 |
Ricard Cervera i Segura | Q53547424 | ||
Pilar Brito Zerón | Q56956066 | ||
Josep Font | Q73474655 | ||
Armando López-Guillermo | Q88697793 | ||
P2093 | author name string | SS-HCV Study Group | |
P2860 | cites work | Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy | Q33348384 |
Hepatitis C virus infection mimicking primary Sjögren syndrome. A clinical and immunologic description of 35 cases | Q34154745 | ||
Efficacy and safety of rituximab in type II mixed cryoglobulinemia | Q40566328 | ||
Hepatitis C virus infection, Sjögren's syndrome, and non-Hodgkin's lymphoma | Q42995896 | ||
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. | Q42996739 | ||
Infection and Lymphoma | Q43748639 | ||
F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy | Q43851581 | ||
P433 | issue | 12 | |
P921 | main subject | Sjögren's syndrome | Q335555 |
rituximab | Q412323 | ||
Hepatitis C virus | Q708693 | ||
B-cell lymphoma | Q4833719 | ||
P304 | page(s) | 969-971 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Treatment of B-cell lymphoma with rituximab in two patients with Sjögren's syndrome associated with hepatitis C virus infection | |
P478 | volume | 13 |
Q35948807 | 'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas. |
Q36951011 | Advances in lupus and Sjögren's syndrome: a tribute to Josep Font |
Q56907510 | Chapter 16 Extrahepatic Manifestations in Patients with Chronic Hepatitis C Virus Infection |
Q46757012 | Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren's syndrome-associated B-cell non-Hodgkin's lymphoma |
Q35638676 | Consensus statement on the use of rituximab in patients with rheumatoid arthritis |
Q42921901 | Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation |
Q36997278 | Conventional therapy of Sjogren's syndrome |
Q37729176 | Emerging biotherapies for Sjögren's syndrome |
Q35731058 | Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection |
Q34098553 | Hepatitis C virus-related lymphoproliferative disorders: an overview. |
Q40238844 | New approaches in Sjögren's syndrome therapy |
Q24644580 | Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma |
Q37366617 | Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with rituximab: report of a case and review of the literature. |
Q33372523 | Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome |
Q36171750 | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007 |
Search more.